The Medical University of Lublin dates back to 1944 in Lublin, Poland. The university gained its autonomy in 1950. Over the years, new departments were added such as the Department of Dentistry in 1973.

During the past decade, Medical University of Lublin conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical University of Lublin" #1 sponsor was "Medical University of Lublin" with 8 trials, followed by "Bio Products Laboratory" with 2 trials sponsored, "Andrea Romano" with 1 trials sponsored, "Ascendis Pharma A/S" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical University of Lublin" #1 collaborator was "Medical University of Lublin" with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "B. Braun Melsungen AG" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Celerion" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Medical University of Lublin" are "Atrial Fibrillation" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Lymphoblastic Leukaemias (ALL)" (1 trials), "Acute Myeloid Leukaemias (AML)" (1 trials) and "Arrhythmia" (1 trials). Many other conditions were trialed in "Medical University of Lublin" in a lesser frequency.

Most popular intervention types in "Medical University of Lublin" are "Drug" (10 trials), "Biological" (4 trials), "Other" (3 trials), "Procedure" (3 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Optivate® (Human Coagulation Factor VIII)" (2 trials), "ACP-001" (1 trials), "Aflibercept" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical University of Lublin" are 19 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Medical University of Lublin". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Medical University of Lublin, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medical University of Lublin, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Medical University of Lublin has several departments that took part in Clinical trials: "IInd Department of Gynecology" - 4 trials, "General Department of Ophthalmology in Lublin" - 4 trials, "Department of Pulmonary Diseases and Children Rheumatology, Medical University of Lublin" - 3 trials, "Second Department of General & Gastrointestinal Surgery & Oncological Surgery of the Alimantary Tract, Medical University of Lublin" - 2 trials, "II Department of Anesthesia and Intensive Care, Medical University of Lublin" - 2 trials, "2nd Department of Anesthesiology and Critical Care, Medical University of Lublin" - 2 trials